The VRI includes 150 researchers working on more than 40 international projects.
Mireille Centlivre is Chief Operating Officer at the Vaccine Research Institute (VRI). She brings over twenty years of experience in biomedical research, with a focus on HIV pathophysiology, vaccine development and preclinical models.
After earning her PhD at the Pasteur Institute (Paris), she completed her postdoc at the Amsterdam Medical Center (AMC-UvA) in the Netherlands and at the Center for Immunology and Infectious Diseases (CIMI-Paris), where she worked on innovative HIV vaccine research and the development of humanized preclinical models. Since 2015, she has joined the VRI.
She plays a key role in scientific coordination, project follow up and management for both national and international programs, and translational research connecting fundamental science to clinical applications within the VRI. She is actively involved in building strategic partnerships with academic and industrial stakeholders, particularly in the field of next-generation vaccine platforms. She has been instrumental in the clinical development of the DC-targeting vaccine portfolio of VRI.